☰

Phapanin Charoenphol, Ph.D. - Publications

Affiliations: 
2012 University of Michigan, Ann Arbor, Ann Arbor, MI 
Area:
Chemical Engineering, Pharmacy
Tree Info Similar researchers PubMed Report error

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Palma-Chavez JA, Fuentes K, Applegate BE, Jo JA, Charoenphol P. Development and Characterization of PLGA-Based Multistage Delivery System for Enhanced Payload Delivery to Targeted Vascular Endothelium. Macromolecular Bioscience. e2000377. PMID 33393217 DOI: 10.1002/mabi.202000377  0.452
2020 Palma-Chavez JA, Kim W, Serafino M, Jo JA, Charoenphol P, Applegate BE. Methylene blue-filled biodegradable polymer particles as a contrast agent for optical coherence tomography. Biomedical Optics Express. 11: 4255-4274. PMID 32923040 DOI: 10.1364/Boe.399322  0.322
2018 Charoenphol P, Oswalt K, Bishop CJ. Therapeutics Incorporating Blood Constituents. Acta Biomaterialia. PMID 29626699 DOI: 10.1016/J.Actbio.2018.03.046  0.487
2016 Kim W, Zebrowski E, Lopez HC, Applegate BE, Charoenphol P, Jo JA. Pump-probe optical coherence tomography using microencapsulated methylene blue as a contrast agent (Conference Presentation) Proceedings of Spie. 9697: 969722. DOI: 10.1117/12.2214829  0.347
2015 Namdee K, Carrasco-Teja M, Fish MB, Charoenphol P, Eniola-Adefeso O. Effect of variation in hemorheology between human and animal blood on the binding efficacy of vascular-targeted carriers. Scientific Reports. 5: 11631. PMID 26113000 DOI: 10.1038/Srep11631  0.627
2014 Sobczynski DJ, Charoenphol P, Heslinga MJ, Onyskiw PJ, Namdee K, Thompson AJ, Eniola-Adefeso O. Plasma protein corona modulates the vascular wall interaction of drug carriers in a material and donor specific manner. Plos One. 9: e107408. PMID 25229244 DOI: 10.1371/Journal.Pone.0107408  0.607
2014 Charoenphol P, Bermudez H. Design and application of multifunctional DNA nanocarriers for therapeutic delivery. Acta Biomaterialia. 10: 1683-91. PMID 23896566 DOI: 10.1016/J.Actbio.2013.07.021  0.313
2013 Namdee K, Thompson AJ, Charoenphol P, Eniola-Adefeso O. Margination propensity of vascular-targeted spheres from blood flow in a microfluidic model of human microvessels. Langmuir : the Acs Journal of Surfaces and Colloids. 29: 2530-5. PMID 23363293 DOI: 10.1021/La304746P  0.843
2012 Charoenphol P, Onyskiw PJ, Carrasco-Teja M, Eniola-Adefeso O. Particle-cell dynamics in human blood flow: implications for vascular-targeted drug delivery. Journal of Biomechanics. 45: 2822-8. PMID 23010218 DOI: 10.1016/J.Jbiomech.2012.08.035  0.8
2011 Charoenphol P, Mocherla S, Bouis D, Namdee K, Pinsky DJ, Eniola-Adefeso O. Targeting therapeutics to the vascular wall in atherosclerosis-Carrier size matters Atherosclerosis. 217: 364-370. PMID 21601207 DOI: 10.1016/J.Atherosclerosis.2011.04.016  0.85
2010 Huang RB, Mocherla S, Heslinga MJ, Charoenphol P, Eniola-Adefeso O. Dynamic and cellular interactions of nanoparticles in vascular-targeted drug delivery. Molecular Membrane Biology. 27: 312-27. PMID 21028938 DOI: 10.3109/09687688.2010.522117  0.766
2010 Huang RB, Mocherla S, Heslinga MJ, Charoenphol P, Eniola-Adefeso O. Dynamic and cellular interactions of nanoparticles in vascular-targeted drug delivery (review). Molecular Membrane Biology. 27: 190-205. PMID 20615080 DOI: 10.3109/09687688.2010.499548  0.76
2010 Charoenphol P, Huang RB, Eniola-Adefeso O. Potential role of size and hemodynamics in the efficacy of vascular-targeted spherical drug carriers. Biomaterials. 31: 1392-402. PMID 19954839 DOI: 10.1016/J.Biomaterials.2009.11.007  0.837
Show low-probability matches.